Site icon AgeWage: Making your money work as hard as you do

Can Artificial Intelligence keep me alive for longer?

It’s been a long-time since I found something as interesting to go to as this. I hope my friends at Club Vita don’t mind me lifting this advert wholesale of social media but the links appear to work so it seems an opportunity to amplify what looks a superb use of an hour at the back end (4-5pm) of Tuesday next week (July 9th).

 

 

The Risk of Living Longer Series, Session 5 of 5: Using Big Data and AI to improve and advance longevity

Uli Stengele (Nationwide Financial) and Douglas Anderson (Club Vita) ask the ultimate question of human longevity for financial institutions: How long can we go?

If many people start achieving significantly longer lifespans, there could be far reaching effects both on society and on our financial institutions. How well is this risk of living longer really understood? People have a tendency to underestimate life expectancy, and actuaries have traditionally based future projections on historical trends. Has groupthink resulted in systematic blind spots in appreciating future longevity risk? Are we overlooking potential black swan events? And do we fully appreciate the differences between insured populations and the general population?

In recent years, some of the world’s top minds – and most bulging wallets – have turned their attention to various aspects of increasing both healthspan and lifespan. Snippets filter down to us through the scientific media, but the questions remain: what are the most likely avenues for progress and how close are we to significant breakthroughs in extending lives?

Register here to join Douglas Anderson and Uli Stengele for the final session of an international multi-disciplinary webinar series where they unpack the key components of the risk of living longer by interviewing a series of experts.

Using Big Data and AI to improve and advance longevity

  • Tuesday July 9th 2024 at 11am-12pm (ET) / 8am-9am (PT) / 4pm-5pm (UK time)
  • Key questions answered:
  • What is the range of longevity related AI use-cases: preventative medicine (such as spotting cancers in scans), accelerating drug discovery, establishing new genetic connections, improving operational efficiency in health delivery?
  • How will the pace of change in longevity be affected by AI developments?
  • Which age groups are likely to be most affected?

Chair

Douglas Anderson

Founder and Chief Visionary Officer, Club Vita

Uli Stengele

Chief Actuary, Nationwide Financial

Our expert panel
Gregg TeHennepe

Senior Director, Computational Sciences, The Jackson Laboratory

Steven Baxter

Head of Innovation and Development, Club Vita

 

Please feel free to email Douglas if you have any questions you’d like the team to address in this webinar.

 

Douglas Anderson

Founder and Chief Visionary Officer, Club Vita

Exit mobile version